GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Tobacco Products » Philip Morris International Inc (NYSE:PM) » Definitions » 12-1 Month Momentum %
中文

Philip Morris International (Philip Morris International) 12-1 Month Momentum % : -7.60% (As of Apr. 24, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Philip Morris International 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-04-24), Philip Morris International's 12-1 Month Momentum % is -7.60%.

The industry rank for Philip Morris International's 12-1 Month Momentum % or its related term are showing as below:

PM's 12-1 Month Momentum % is ranked worse than
53.7% of 54 companies
in the Tobacco Products industry
Industry Median: -6.385 vs PM: -7.60

Competitive Comparison of Philip Morris International's 12-1 Month Momentum %

For the Tobacco subindustry, Philip Morris International's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Philip Morris International's 12-1 Month Momentum % Distribution in the Tobacco Products Industry

For the Tobacco Products industry and Consumer Defensive sector, Philip Morris International's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Philip Morris International's 12-1 Month Momentum % falls into.



Philip Morris International  (NYSE:PM) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Philip Morris International  (NYSE:PM) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Philip Morris International 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Philip Morris International's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Philip Morris International (Philip Morris International) Business Description

Address
677 Washington Boulevard, Suite 1100, Stamford, Connecticut, New York, NY, USA, 06901
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from cigarettes with the 2022 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches, primarily in the U.S. and Scandinavia. It diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Executives
Wilde Frederic De officer: Sr. VP, Marketing & Sales 120 PARK AVENUE, NEW YORK NY 10017
Yann Guerin officer: SVP & Global Head of L&C 677 WASHINGTON BLVD., SUITE 1100, STAMFORD CT 06901
Werner Barth officer: Sr. VP, Marketing and Sales 120 PARK AVENUE, NEW YORK NY 10017
Lars Dahlgren officer: Pres. Smoke-Free Oral Products 677 WASHINGTON BLVD., STAMFORD CT 06896
Dessislava Temperley director C/O CIMPRESS PLC, 275 WYMAN STREET, WALTHAM MA 02451
Reginaldo Dobrowolski officer: Vice President and Controller 677 WASHINGTON BLVD, SUITE 1100, STAMFORD CT 06901
Martin G. King officer: SVP Operations 120 PARK AVENUE, NEW YORK NY 10017
Paul Riley officer: Pres East Asia & Australia 120 PARK AVENUE, NEW YORK NY 10017
Drago Azinovic officer: Pres., European Union Region 120 PARK AVENUE, NEW YORK NY 10017
Mario Masseroli officer: Pres., Latin America & Canada 120 PARK AVENUE, NEW YORK NY 10017
Juan J. Daboub director 5100 W. 115TH PLACE, LEAWOOD KS 66211
Shlomo Yanai director ONE MEADOWLANDS PLAZA, EAST RUTHERFORD NJ 07073
Stacey Kennedy officer: Pres. South & Southeast Asia 120 PARK AVENUE, NEW YORK NY 10017
Charles Bendotti officer: Senior VP, Human Resources 120 PARK AVENUE, NEW YORK NY 10017
Andre Calantzopoulos director, officer: President & CEO 677 WASHINGTON BLVD, SUITE 1100, STAMFORD CT 06901